Search Results 111-120 of 741 for ⌛구글정보이용료 (010-9489-1116) 소액결제현금화⌛

  1. Extent of Donor Site Morbidity after Scaphoid Repair Surgery Using the Medial Femoral Condyle - Mayo Clinic

    Overview · Participation eligibility · Participating Mayo Clinic locations · More information · Additional contact information.

  2. A Study of the Safety and Effectiveness of NEOD001 for Treating Previously Treated Patients with Persistent Cardiac Dysfunction Related to Light Chain Amyloidosis - Mayo Clinic

    About this study. The purpose of this study is to assess the effectiveness and safety of NEOD001 administered intravenously in adults with light chain ...

  3. The Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy - Mayo Clinic

    Overview · Participation eligibility · Participating Mayo Clinic locations · More information · Additional contact information.

  4. Longitudinal Effects of Diabetes-Associated Variation in TCF7L2 on Glucagon and Insulin Secretion in Non-Diabetic Humans - Mayo Clinic

    The goal of this study is to determine the role of postprandial glucagon suppression and insulin secretion in the progression of glucose intolerance in people ...

  5. Compassionate Use of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome - Mayo Clinic

    Overview · Participation eligibility · Participating Mayo Clinic locations · More information · Additional contact information.

  6. Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma - Mayo Clinic

    To evaluate the efficacy and safety of lenalidomide, rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R2-CHOP) chemotherapy versus placebo ...

  7. Validation of Gene Expression Markers of Renal Allograft Functional Decline - Mayo Clinic

    Overview · Participation eligibility · Participating Mayo Clinic locations · More information ...

  8. CYP2C19 Genotype Predictor of Gastric Acid Suppression - Mayo Clinic

    About this study. If CYP2C19 genotype can predict the efficacy of healing erosive esophagitis and gastric acid secretion in patients taking once a day ...

  9. Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR) - Mayo Clinic

    Overview · Participation eligibility · Participating Mayo Clinic locations · More information · Additional contact information.

  10. A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy - Mayo Clinic

    Overview · Participation eligibility · Participating Mayo Clinic locations · More information ...